Yulan Li

On the Lower Predictive Bound Approach for Noninferiority Clinical Trials with Binary Data

Qing Liu, Yulan Li, 2014, Journal of biopharmaceutical statistics.

On Adaptive Error Spending Approach for Group Sequential Trials with Random Information Levels

Qing Liu, P. Lim, Yulan Li, 2012, Journal of biopharmaceutical statistics.

Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients

W. Weimar, K. Budde, R. Margreiter, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Everolimus versus Mycophenolate Mofetil in the Prevention of Rejection in De Novo Renal Transplant Recipients: A 3-Year Randomized, Multicenter, Phase III Study

S. Mulgaonkar, H. Sollinger, R. Mendez, 2005, Transplantation.

Everolimus (Certican) 12-Month Safety and Efficacy Versus Mycophenolate Mofetil in de Novo Renal Transplant Recipients

Raimund Margreiter, W. Weimar, A. Jappe, 2004, Transplantation.

Therapeutic drug monitoring for everolimus in kidney transplantation using 12‐month exposure, efficacy, and safety data

Heinz Schmidli, J. Kovarik, C. Ponticelli, 2005, Clinical transplantation.

Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.

P. Houghton, J. Houghton, C. Stewart, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.